JESSE DOMINGUEZ: Open Payments
NPI 1467534313 · FONTANA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$922 in 45 payments from 15 companies in 2025. Trend: 2023 $1,112 · 2024 $998 · 2025 $922
Food & beverage: $922
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 8 | $168 |
| Novo Nordisk Inc | 6 | $104 |
| Lilly USA, LLC | 4 | $98 |
| Exact Sciences Corporation | 4 | $84 |
| PFIZER INC. | 3 | $77 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $66 |
| AstraZeneca Pharmaceuticals LP | 3 | $52 |
| SANOFI-AVENTIS U.S. LLC | 3 | $51 |
| Amgen Inc. | 2 | $38 |
| Xeris Pharmaceuticals, Inc. | 2 | $38 |
Products named: FREESTYLE LIBRE 3, The Cologuard Plus Collection Kit, PREVNAR 20, XIFAXAN, Rybelsus, TZIELD, KISUNLA, OTEZLA.
Industry payments across CA — which companies pay providers there.
